Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;10(1):208-219.
doi: 10.1002/cam4.3605. Epub 2020 Nov 18.

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

Murat Gultekin  1   2 , Sertac Ak  3   4 , Ali Ayhan  5 , Aleksandra Strojna  6 , Andrei Pletnev  7 , Anna Fagotti  8 , Anna Myriam Perrone  9 , B Emre Erzeneoglu  1 , B Esat Temiz  1 , Birthe Lemley  2   10 , Burcu Soyak  1 , Cathy Hughes  11   12 , David Cibula  13 , Dimitrios Haidopoulos  14 , Donal Brennan  15 , Edoardo Cola  8 , Elzbieta van der Steen-Banasik  16 , Esra Urkmez  2   17 , Huseyin Akilli  5 , Ignacio Zapardiel  18 , Icó Tóth  2   19 , Jalid Sehouli  20 , Kamil Zalewski  2   21   22   23 , Kiarash Bahremand  24 , Luis Chiva  25 , Mansoor Raza Mirza  26 , Maria Papageorgiou  2   27 , Novak Zoltan  24 , Petra Adámková  2   28 , Philippe Morice  29 , Sonia Garrido-Mallach  18 , Utku Akgor  1 , Vasilis Theodoulidis  14 , Zafer Arik  30 , Karina D Steffensen  2   31   32   33 , Christina Fotopoulou  12
Affiliations

Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe)

Murat Gultekin et al. Cancer Med. 2021 Jan.

Abstract

Background: The impact of the COVID-19 pandemic on European gynaecological cancer patients under active treatment or follow-up has not been documented. We sought to capture the patient perceptions of the COVID-19 implications and the worldwide imposed treatment modifications.

Methods: A patient survey was conducted in 16 European countries, using a new COVID-19-related questionnaire, developed by ENGAGe and the Hospital Anxiety & Depression Scale questionnaire (HADS). The survey was promoted by national patient advocacy groups and charitable organisations.

Findings: We collected 1388 forms; 592 online and 796 hard-copy (May, 2020). We excluded 137 due to missing data. Median patients' age was 55 years (range: 18-89), 54.7% had ovarian cancer and 15.5% were preoperative. Even though 73.2% of patients named cancer as a risk factor for COVID-19, only 17.5% were more afraid of COVID-19 than their cancer condition, with advanced age (>70 years) as the only significant risk factor for that. Overall, 71% were concerned about cancer progression if their treatment/follow-up was cancelled/postponed. Most patients (64%) had their care continued as planned, but 72.3% (n = 892) said that they received no information around overall COVID-19 infection rates of patients and staff, testing or measures taken in their treating hospital. Mean HADS Anxiety and Depression Scores were 8.8 (range: 5.3-12) and 8.1 (range: 3.8-13.4), respectively. Multivariate analysis identified high HADS-depression scores, having experienced modifications of care due to the pandemic and concern about not being able to visit their doctor as independent predictors of patients' anxiety.

Interpretation: Gynaecological cancer patients expressed significant anxiety about progression of their disease due to modifications of care related to the COVID-19 pandemic and wished to pursue their treatment as planned despite the associated risks. Healthcare professionals should take this into consideration when making decisions that impact patients care in times of crisis and to develop initiatives to improve patients' communication and education.

Keywords: COVID-19; EU; anxiety; cancer; depression; expectation; gynaecologic oncology; patients; perspectives.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

FIGURE 1
FIGURE 1
HADS Depression (A) and Anxiety (B) Scores
See this image and copyright information in PMC

References

    1. Raymond E, Thieblemont C, Alran S, Faivre S. Impact of the COVID‐19 outbreak on the management of patients with cancer. Target Oncol. 2020;22:1‐11. - PMC - PubMed
    1. Glehen O, Kepenekian V, Bouché O, Gladieff L, Honore C, RENAPE‐BIG‐RENAPE . Treatment of primary and metastatic peritoneal tumors in the COVID‐19 pandemic. Proposals for prioritization from the RENAPE and BIG‐RENAPE groups. J Visc Surg. 2020;23:S1878–7886(20), 30118–1. - PMC - PubMed
    1. Desideri I, Pilleron S, Battisti NML, et al. Caring for older patients with cancer during the COVID‐19 pandemic: a young international society of geriatric oncology (SIOG) global perspective. Geriatr Oncol. 2020;S1879–4068(20)30215–0. - PMC - PubMed
    1. Wang Y, Zhang S, Wei L, et al. Recommendations on management of gynecological malignancies during the COVID‐19 pandemic: perspectives from Chinese gynecological oncologists. J Gynecol Oncol. 2020. 10.3802/jgo.2020.31.e68. Online ahead of print - DOI - PMC - PubMed
    1. Vecchione L, Stintzing S, Pentheroudakis G, Douillard JY, Lordick F. ESMO management and treatment adapted recommendations in the COVID‐19 era: colorectal cancer. ESMO Open. 2020;5(Suppl 3):e000826 10.1136/esmoopen-2020-000826 - DOI - PMC - PubMed

MeSH terms